Neonatal sepsis in South Asia: huge burden and spiralling antimicrobial resistance

Suman Chaurasia; Sindhu Sivanandan; Ramesh Agarwal; Sally Ellis; Mike Sharland; M Jeeva Sankar

doi:10.1136/bmj.k5314

Neonatal sepsis in South Asia: huge burden and spiralling antimicrobial resistance

BMJ. 2019 Jan 22:364:k5314. doi: 10.1136/bmj.k5314.

Authors

Suman Chaurasia¹, Sindhu Sivanandan¹, Ramesh Agarwal¹, Sally Ellis², Mike Sharland³, M Jeeva Sankar⁴

Affiliations

¹ Department of Paediatrics, All India Institute of Medical Sciences, New Delhi, India.
² Global Antibiotic R&D Partnership, Drugs for Neglected Diseases initiative, Geneva, Switzerland.
³ Paediatric Infectious Diseases Research Group, St George's University London, UK.
⁴ Department of Paediatrics, All India Institute of Medical Sciences, New Delhi, India [email protected].

Abstract

M Jeeva Sankar and colleagues call for urgent action to improve quality of care at birth and implement antimicrobial stewardship in health facilities in South Asia to reduce neonatal deaths from sepsis

Publication types

Review

MeSH terms

Anti-Bacterial Agents / therapeutic use*
Antimicrobial Stewardship*
Asia / epidemiology
Drug Resistance, Bacterial*
Humans
Incidence
Infant, Newborn
Neonatal Sepsis / drug therapy*
Neonatal Sepsis / epidemiology*
Neonatal Sepsis / microbiology
Quality of Health Care*

Substances

Anti-Bacterial Agents